Drug
Intrathecal nalbuphine and spinal anesthesia
Intrathecal nalbuphine and spinal anesthesia is a pharmaceutical drug with 2 clinical trials. Currently 2 active trials ongoing.
Total Trials
2
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
2(100%)
Phase Distribution
Ph not_applicable
2
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
2
all time
Status Distribution
Active(2)
Detailed Status
Active, not recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
2
Active
2
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
active_not_recruiting150%
recruiting150%
Recent Activity
2 active trials
Showing 2 of 2
active_not_recruitingnot_applicable
Comparison of Intrathecal Nalbuphine Versus Intrathecal Tramadol as Adjuvants in Subarachnoid Block for Lower Limb Orthopaedic Surgeries
NCT07294352
recruitingnot_applicable
Analgesic Efficacy of Fascia Iliaca Compartment Block Compared With Intrathecal Nalbuphine for Hip Surgery Under Spinal Anesthesia
NCT06818396
Clinical Trials (2)
Showing 2 of 2 trials
NCT07294352Not Applicable
Comparison of Intrathecal Nalbuphine Versus Intrathecal Tramadol as Adjuvants in Subarachnoid Block for Lower Limb Orthopaedic Surgeries
NCT06818396Not Applicable
Analgesic Efficacy of Fascia Iliaca Compartment Block Compared With Intrathecal Nalbuphine for Hip Surgery Under Spinal Anesthesia
All 2 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 2